LOSS OF EFFICACY OF ANTI-RHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS

被引：0
|
作者：
ROSENTHAL, M
机构：
来源：
JOURNAL OF RHEUMATOLOGY | 1980年 / 7卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：586 / 587
页数：2
相关论文
共 50 条
  • [21] Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Choy, Ernest
    Aletaha, Daniel
    Behrens, Frank
    Finckh, Axel
    Gomez-Reino, Juan
    Gottenberg, Jacques-Eric
    Schuch, Florian
    Rubbert-Roth, Andrea
    [J]. RHEUMATOLOGY, 2017, 56 (05) : 689 - 697
  • [22] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Monchablon, Clelia
    Gonde, Henri
    Pouplin, Sophie
    Varin, Remi
    Vittecoq, Olivier
    Lequerre, Thierry
    [J]. CLINICAL RHEUMATOLOGY, 2020, 39 (01) : 207 - 216
  • [23] Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis
    van Jaarsveld, CHM
    Jahangier, ZN
    Jacobs, JWG
    Blaauw, AAM
    van Albada-Kuipers, GA
    ter Borg, EJ
    Brus, HLM
    Schenk, Y
    van der Veen, MJ
    Bijlsma, JWJ
    [J]. RHEUMATOLOGY, 2000, 39 (12) : 1374 - 1382
  • [24] A short history of anti-rheumatic therapy - VI. Rheumatoid arthritis drugs
    Pasero, G.
    Marson, P.
    [J]. REUMATISMO, 2011, 63 (02) : 111 - 123
  • [25] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Clélia Monchablon
    Henri Gondé
    Sophie Pouplin
    Rémi Varin
    Olivier Vittecoq
    Thierry Lequerré
    [J]. Clinical Rheumatology, 2020, 39 : 207 - 216
  • [26] SLOW ONSET ANTI-RHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS - COULD THE PRESENCE OF ANTI-NUCLEAR ANTIBODY INFLUENCE THE THERAPEUTIC RESULTS
    MENARD, H
    MATHIEU, J
    MEDICIS, RD
    LUSSIER, A
    [J]. JOURNAL OF RHEUMATOLOGY, 1979, 6 (02) : 156 - 162
  • [27] Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors: differences in efficacy and safety in rheumatoid arthritis
    Roy Fleischmann
    [J]. Clinical Rheumatology, 2021, 40 : 4369 - 4372
  • [28] Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Fan, Junyu
    Jiang, Ting
    He, Dongyi
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [29] Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors: differences in efficacy and safety in rheumatoid arthritis
    Fleischmann, Roy
    [J]. CLINICAL RHEUMATOLOGY, 2021, 40 (11) : 4369 - 4372
  • [30] DISEASE MODIFYING ANTI-RHEUMATIC DRUG (DMARD) TREATMENT OF CLASSICAL RHEUMATOID-ARTHRITIS (RA)
    RASMUSSEN, EK
    HALBERG, P
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1984, : 122 - 122
12345